Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Colombia”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Colombia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2015, the population of Colombia was approximately 48.2 million, growing at a Compound Annual Growth Rate (CAGR) of 1.2%, over the 2008-2015 period. The value of the pharmaceutical market was estimated at $5 billion in 2015, and is expected to reach $7.1 billion by 2020, increasing at a projected CAGR of 7.3%.

The positive trends in the healthcare market of Colombia can be attributed primarily to -

  • Increasing awareness of health and well-being in society
  • Increasing affordability and compliance
  • A strategic move by the Colombian government towards compulsory health insurance
Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Colombia, and includes -
  • An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are Tecnoquimicas, Pfizer, Merck, Roche and Procaps.
  • An insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies, and market authorization processes for new drug and medical devices
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure, and healthcare expenditures
  • An overview of the opportunities and challenges for growth in the healthcare market
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Colombia healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Colombia’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData Report Guidance
3 Overview of the Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Pharmaceutical Exports and Imports
3.1.3 Supply Channels
3.1.4 Market Segments
3.1.5 Major Disease Areas
3.1.6 Major Companies
3.2 Medical Device Market
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share in Healthcare Spending
4.1.5 Price Trends in Healthcare Sector
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Market Authorization Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of the Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 General Government Structural Balance
5.3.9 General Government Net Debt
5.3.10 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Parameters
5.5.2 Environmental Health
5.5.3 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview
5.6.2 Major Components of Healthcare Spending
5.6.3 Public and Private Sector Share
5.7 Trade Associations
5.7.1 Colombian Pharmaceutical Industry Association
5.7.2 Association of Pharmaceutical Laboratories Research
5.7.3 National Academy of Medicine of Colombia
5.7.4 Colombian Association of Integrative Medicine Business
5.7.5 The Colombian Association of Medical Schools
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasts
7.3.4 Expert Panel
7.4 Disclaimer
1.1 List of Tables
Table 1: Pharmaceutical Market, Colombia, Revenue ($bn), 2008-2015
Table 2: Pharmaceutical Market, Colombia, Revenue ($bn), 2016-2020
Table 3: Pharmaceutical Market, Colombia, Exports and Imports ($m), 2008-2015
Table 4: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016
Table 5: Pharmaceutical Market, Merck & Co., Global, Major Products, 2015
Table 6: Pharmaceutical Market, Merck & Co., Global, Late-Stage Pipeline, 2016
Table 7: Pharmaceutical Market, Roche, Global, Major Products, Revenue ($m) and Annual Growth (%), 2013
Table 8: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2016
Table 9: Medical Device Market, Colombia, Revenue ($bn), 2008-2015
Table 10: Medical Device Market, Colombia, Revenue ($bn), 2016-2020
Table 11: Market Access, Colombia, Out-of-Pocket Payments as a Percentage of Total Healthcare Expenditure (%), 2008-2015
Table 12: Market Access, Colombia, Change in Average Price of Healthcare Services (%), 2008-2015
Table 13: Regulatory Landscape, Colombia, Trademark Filing Fees and Charges, 2016
Table 14: Economic Indicators, Colombia, Gross Domestic Product per Capita ($), 2008-2015
Table 15: Economic Indicators, Colombia, GDP per Capita Forecast ($), 2016-2020
Table 16: Economic Indicators, Colombia, GDP Annual Growth (%), 2008-2015
Table 17: Economic Indicators, Colombia, GDP Annual Growth (%), 2016-2020
Table 18: Economic Indicators, Colombia, Gross National Income per Capita ($), 2008-2015
Table 19: Economic Indicators, Colombia, Consumer Price Index, 2008-2015
Table 20: Economic Indicators, Colombia, Consumer Price Index, 2016-2020
Table 21: Economic Indicators, Colombia, Consumer Price Annual Change (%), 2008-2015
Table 22: Economic Indicators, Colombia Currency Exchange Rate ($/COP) 2008-2015
Table 23: Economic Indicators, Colombia, Foreign Direct Investment ($bn), 2008-2015
Table 24: Economic Indicators, Colombia, Foreign Exchange Reserves ($bn), 2008-2015
Table 25: Economic Indicators, Colombia, Imports of Goods and Services ($bn), 2008-2015
Table 26: Economic Indicators, Colombia, Exports of Goods and Services ($bn), 2008-2015
Table 27: Economic Indicators, Colombia, Government Structural Balance ($bn), 2008-2015
Table 28: Economic Indicators, Colombia, General Government Net Debt ($bn), 2008-2015
Table 29: Economic Indicators, Colombia, General Government Net Debt Forecast ($bn), 2016-2020
Table 30: Economic Indicators, Colombia, Major Industries, Population Employed (million), 2015
Table 31: Demographics, Colombia, Population (million), 2008-2015
Table 32: Demographics, Colombia, Population (million), 2016-2020
Table 33: Demographics, Colombia, Urban-Rural Population Share (%), 2008-2015
Table 34: Demographics, Colombia, Urban-Rural Population Share (%), 2016-2020
Table 35: Demographics, Colombia, Population Distribution by Age Group (%), 2008-2015
Table 36: Demographics, Colombia, Population Distribution by Age Group Forecast (%), 2016-2020
Table 37: Demographics, Colombia, Births (per 1,000 population), 2008-2015
Table 38: Demographics, Colombia, Mortality (per 1,000 population), 2008-2015
Table 39: Demographics, Colombia, Major Causes of Mortality (%), 2015
Table 40: Demographics, Colombia, Mortality Rate in Children under Five (per 1,000 live births), 2008-2015
Table 41: Demographics, Colombia, Immunization Rate (%), 2008-2013
Table 42: Demographics, Colombia, Major Causes of Male Mortality (‘000), 2011
Table 43: Demographics, Colombia, Major Causes of Female Mortality (‘000), 2011
Table 44: Demographics, Colombia, Gender Ratio (M/F), 2008-2015
Table 45: Demographics, Colombia, Life Expectancy at Birth (years), 2008-2015
Table 46: Demographics, Colombia, Gross Enrollment by Level of Education (%), 2008-2015
Table 47: Demographics, Colombia, Unemployment Rate (%), 2008-2015
Table 48: Demographics, Colombia, Patients hospitalized (%), 2014
Table 49: Demographics, Colombia, Disability-Adjusted Life Years by Major Disease (‘000), 2012
Table 50: Healthcare Infrastructure, Colombia, Hospital Beds (per 1,000 population), 2008-2015
Table 51: Healthcare Infrastructure, Colombia, Doctors (per 1,000 population), 2008-2015
Table 52: Healthcare Infrastructure, Colombia, PM2.5 (µg/m3), 2008-2015
Table 53: Healthcare Infrastructure, Colombia, CO2 Emissions (metric tons per capita), 2008-2015
Table 54: Healthcare Infrastructure, Colombia, Nurses (per 1,000 population), 2008-2015
Table 55: Healthcare Infrastructure, Colombia, Dentists (per 1,000 population), 2008-2015
Table 56: Healthcare Expenditure, Colombia, Healthcare Expenditure (% of GDP), 2008-2015
Table 57: Healthcare Expenditure, Colombia, Share of Major Components (%), 2014
Table 58: Healthcare Expenditure, Colombia, Healthcare Expenditure, Public-Private Share (%), 2008-2015
Table 59: Healthcare Expenditure, Colombia, Major Healthcare Trade Fairs, 2016
1.2 List of Figures
Figure 1: Pharmaceutical Market, Colombia, Revenue ($bn), 2008-2020
Figure 2: Medical Device Market, Colombia, Revenue ($m), 2008-2020
Figure 3: Country Profile, Colombia, 2016
Figure 4: Pharmaceutical Market, Colombia, Revenue ($bn), 2008-2015
Figure 5: Pharmaceutical Market, Colombia, Revenue ($bn), 2016-2020
Figure 6: Pharmaceutical Market, Colombia, Exports and Imports ($m), 2008-2015
Figure 7: Medical Device Market, Colombia, Revenue ($bn), 2008-2015
Figure 8: Medical Device Market, Colombia, Revenue ($bn), 2016-2020
Figure 9: Healthcare Market, Colombia, Drivers and Barriers, 2016
Figure 10: Market Access, Colombia, Overview of Healthcare System
Figure 11: Market Access, Colombia, Overview of Healthcare System
Figure 12: Market Access, Colombia, Out-of-Pocket Payments as a Percentage of Total Healthcare Expenditure (%), 2008-2015
Figure 13: Market Access, Colombia, Change in Average Price of Healthcare Services (%), 2008-2015
Figure 14: SISMED Monitoring Process, Colombia, 2012
Figure 15: Structure of INVIMA, Colombia, 2012
Figure 16: Market Access, Colombia, Marketing Authorization Procedure, 2015
Figure 17: Regulatory Landscape, Colombia, Generic Drug Approval Process, 2015
Figure 18: Licensing Process for Manufacturing, Colombia, 2012
Figure 19: Market Access, Colombia, Patent Approval Process, 2014
Figure 20: Economic Indicators, Colombia, Gross Domestic Product per Capita ($), 2008-2015
Figure 21: Economic Indicators, Colombia, GDP per Capita ($), 2016-2020
Figure 22: Economic Indicators, Colombia, GDP Annual Growth (%), 2008-2015
Figure 23: Economic Indicators, Colombia, GDP Annual Growth (%), 2016-2020
Figure 24: Economic Indicators, Colombia, Gross National Income per Capita ($), 2008-2015
Figure 25: Economic Indicators, Colombia, Consumer Price Index, 2008-2015
Figure 26: Economic Indicators, Colombia, Consumer Price Index, 2016-2020
Figure 27: Economic Indicators, Colombia, Consumer Price Annual Change (%), 2008-2015
Figure 28: Economic Indicators, Colombia, Currency Exchange Rate ($/COP) 2008-2015
Figure 29: Economic Indicators, Colombia, Foreign Direct Investment ($bn), 2008-2015
Figure 30: Economic Indicators, Colombia, Foreign Exchange Reserves ($bn), 2008-2015
Figure 31: Economic Indicators, Colombia, Imports of Goods and Services ($bn), 2008-2015
Figure 32: Economic Indicators, Colombia, Exports of Goods and Services ($bn), 2008-2015
Figure 33: Economic Indicators, Colombia, Government Structural Balance ($bn), 2008-2015
Figure 34: Economic Indicators, Colombia, General Government Net Debt ($bn), 2008-2015
Figure 35: Economic Indicators, Colombia, General Government Net Debt ($bn), 2016-2020
Figure 36: Economic Indicators, Colombia, Major Industries, Population Employed (million), 2015
Figure 37: Demographics, Colombia, Population (million), 2008-2015
Figure 38: Demographics, Colombia, Population (million), 2016-2020
Figure 39: Demographics, Colombia, Urban-Rural Population Share (%), 2008-2015
Figure 40: Demographics, Colombia, Urban-Rural Population Share (%), 2016-2020
Figure 41: Demographics, Colombia, Population Distribution by Age Group (%), 2008-2015
Figure 42: Demographics, Colombia, Population Distribution by Age Group (%), 2016-2020
Figure 43: Demographics, Colombia, Births (per 1,000 population), 2008-2015
Figure 44: Demographics, Colombia, Mortality (per 1,000 population), 2008-2015
Figure 45: Demographics, Colombia, Major Causes of Mortality (%), 2015
Figure 46: Demographics, Colombia, Mortality Rate in Children under Five (per 1,000 live births), 2008-2015
Figure 47: Demographics, Colombia, Immunization Rate (%), 2008-2015
Figure 48: Demographics, Colombia, Major Causes of Male Mortality (‘000), 2011
Figure 49: Demographics, Colombia, Major Causes of Female Mortality (‘000), 2011
Figure 50: Demographics, Colombia, Gender Ratio (M/F), 2008-2015
Figure 51: Demographics, Colombia, Life Expectancy at Birth (years), 2008-2015
Figure 52: Demographics, Colombia, Gross Enrollment by Level of Education (%), 2008-2015
Figure 53: Demographics, Colombia, Unemployment Rate (%), 2008-2015
Figure 54: Demographics, Colombia, Patients hospitalized, 2014
Figure 55: Demographics, Colombia, Disability-Adjusted Life Years by Major Disease (‘000), 2012
Figure 56: Healthcare Infrastructure, Colombia, Hospital Beds (per 1,000 population), 2008-2015
Figure 57: Healthcare Infrastructure, Colombia, Doctors (per 1,000 population), 2008-2015
Figure 58: Healthcare Infrastructure, Colombia, PM2.5 (µg/m3), 2008-2015
Figure 59: Healthcare Infrastructure, Colombia, CO2 Emissions (metric tons per capita), 2008-2015
Figure 60: Healthcare Infrastructure, Colombia, Nurses (per 1,000 population), 2008-2015
Figure 61: Healthcare Infrastructure, Colombia, Dentists (per 1,000 population), 2008-2015
Figure 62: Healthcare Expenditure, Colombia, Healthcare Expenditure (% of GDP), 2008-2015
Figure 63: Healthcare Expenditure, Colombia, Public Healthcare Expenditure, Share of Major Components (%), 2013
Figure 64: Healthcare Expenditure, Colombia, Public-Private Share of Healthcare Expenditure (%), 2008-2015
Figure 65: Healthcare Market, Colombia, Opportunities and Challenges, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report